iSpecimen Inc. Balance Sheet
ISPC|5 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
iSpecimen Inc. had $10M in total assets and $3M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.90 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | - | $1.9M | $2.3M | $27.7M | $27.7M |
| Accounts Receivable | $48.3K | $1.4M | $728.4K | $3.0M | $3.0M |
| Current Assets | $7.0M | $3.6M | $8.2M | $32.9M | $32.9M |
| PP&E (Net) | $25.5K | $93.6K | $127.8K | $32.8K | $32.8K |
| Total Assets | $9.5M | $9.4M | $15.8M | $35.7M | $35.7M |
| Current Liabilities | $6.2M | $5.8M | $6.0M | $2.5M | $2.5M |
| Shareholders' Equity | $3.3M | $9.7M | $20.3M | -$27.3M | -$27.3M |